Pattern of Intermediate Uveitis in an Egyptian Cohort. (2nd April 2020)

• Record Type: Journal Article
• Authors: Abd El Latif, Eiman; Abdelhalim, Ahmed Shawkat; Montasser, Ahmed Samir; Said, Mohamed Hassan; Shikhoun Ahmed, Mohammed; Abdel Kader Fouly Galal, Marwa; Ibrahim, Walid; Samy Abd Elaziz, Mohamed; Fathi Abuelkheir, Amr; Elbarbary, Hossameldeen; Elsayed, Ayman M. Abdelrahman; Lotfy, Ayman; Elmorsy, Osama A.; Gab-Alla, Amr A.; Hatata, Ragai Magdy; Abousamra, Amir Alyeldin Hassan; Farouk, Mahmoud Mohamed; Elbakary, Molham A.; Awara, Amr Mahmoud; Amer, Ibrahim; Elzawahry, Walid Mohamed Abd Elraouf; Kandil, Hazem W.; Barrada, Omar A.; Bakr Elessawy, Kareem; Zayed, Mohamed A.; El Hennawi, Hazem; Tawfik, Mohamed A.
• Is Part Of: Ocular immunology and inflammation. Volume 28:Number 3(2020)
• Page Start: 524
• Page End: 531
• Publication Date: 2020-04-02
• Subjects: Egypt -- epidemiology -- intermediate uveitis -- multiple sclerosis -- sarcoidosis; Eye -- Diseases -- Immunological aspects -- Periodicals; Eye -- Inflammation -- Periodicals; 617.7
• DOI: 10.1080/09273948.2019.1668429
• Languages: English
• ISSNs: 0927-3948

Abstract

ABSTRACT: Purpose : To describe the clinical experience with intermediate uveitis at six Egyptian tertiary eye centers. Methods : A multicenter retrospective chart review of all patients with intermediate uveitis seen at six ocular inflammation referral clinics in Egypt between January 2010 and January 2017. Results : The study included a total of 781 patients with intermediate uveitis. The study cohort comprised of 282 male and 499 female patients. In over half of our cohort (58.77%), no specific cause could be confirmed. The remaining patients had sarcoidosis (16.26%), tuberculosis (14.85%), multiple sclerosis (9.09%), and TINU (1.02%). By the end of our study, 62% of the affected eyes had a BCVA better than 20/40 Conclusion : More than 40% of our patients with intermediate uveitis had sarcoidosis, tuberculosis, multiple sclerosis, or TINU as the underlying etiology. Owing to their potential morbidity, these diseases need to be considered in Egyptian patients presenting with intermediate uveitis.